NCT06716190View on ClinicalTrials.gov

A Study to Test How Different Doses of BI 3731579 Are Tolerated by Healthy People

PHASE1TerminatedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 18, 2024

Primary Completion Date

June 5, 2025

Study Completion Date

June 5, 2025

Conditions
Healthy
Interventions
DRUG

BI 3731579

BI 3731579

DRUG

Placebo matching BI 3731579

Placebo matching BI 3731579

DRUG

Midazolam

Midazolam

Trial Locations (1)

2650

SGS Life Science Services - Clinical Research, Edegem

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY